Future of the drug label: Perspectives from a multistakeholder dialogue.
Br J Clin Pharmacol
; 85(10): 2442-2445, 2019 10.
Article
em En
| MEDLINE
| ID: mdl-31317570
ABSTRACT
Regulating drugs does not end when market access has been granted. Monitoring drugs over the life cycle has become state of the art, inherent to evolving legislation and societal need. Here, we explore how the drug label could move along in a changing playing-field and become a sustainable label for the future. A dialogue between academia, government, the pharmaceutical industry and patient/societal organizations was organized by the Regulatory Science Network Netherlands. This is their view.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Controle de Medicamentos e Entorpecentes
/
Indústria Farmacêutica
/
Rotulagem de Medicamentos
Limite:
Humans
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article